Diabetes

Insulin LY2605541 tops glargine for glycemic control in T1DM

(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published online Nov. 27 ...

Diabetes

Low insulin secretion tied to depressive symptoms in women

(HealthDay)—Middle-aged women with insulin secretion levels in the lowest quintile appear to have more than twice the risk of developing new-onset depressive symptoms compared with those with higher insulin secretion levels, ...

Diabetes

Number of U.S. kids with diabetes could skyrocket, study finds

(HealthDay)—If the current trends in diabetes for young people stay the same, rates of type 2 diabetes will rise by 49 percent by 2050, and rates of type 1 diabetes will increase by 23 percent, according to new government ...

Diabetes

New gene-therapy approach could improve obesity treatment

(Medical Xpress)—Medical researchers at the University of Alberta have found a new way of using gene therapy to treat obesity. The treatment was successful, resulting in less weight gain, higher activity levels and decreased ...

Diabetes

Confusion over diabetes types adds to patients' woes

(HealthDay)—Given that about one in 12 Americans has diabetes, chances are good you know someone with some form of the disease. But you may be less informed about the different types of diabetes and their causes and treatments. ...

Diabetes

Early intensive diabetes therapy preserves beta-cell function

(HealthDay) -- Early, intensive therapy for type 2 diabetes with either insulin plus metformin or triple oral therapy preserves β-cell function for at least 3.5 years, according to a study published in the July issue ...

page 8 from 11